Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Accumulated Expenses (2012 - 2026)

Precigen (PGEN) posted quarterly Accumulated Expenses of $4.6 million for Q1 2026, down 52.65% year-over-year from $9.6 million in Q1 2025, and down 55.33% quarter-over-quarter from $10.2 million in Q4 2025.

Analysis

Precigen (PGEN) Accumulated Expenses (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Accumulated Expenses for 15 consecutive years, with $4.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accumulated Expenses fell 52.65% year-over-year to $4.6 million; the TTM figure through Mar 2026 stood at $4.6 million (down 52.65% YoY), while the FY2025 annual figure was $10.2 million, up 21.17% from the prior year.
  • Accumulated Expenses declined to $4.6 million in Q1 2026 per PGEN's latest filing, from $10.2 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $10.2 million in Q4 2025 and bottomed at $4.6 million in Q1 2026.
  • Historically, Accumulated Expenses has averaged $7.0 million across 5 years, with a median of $6.6 million in 2024.
  • Annual changes were most pronounced in 2024 — Accumulated Expenses surged 100.89% — and 2026, when it slumped 52.65%.
  • Precigen's Accumulated Expenses stood at $6.4 million in 2022, then advanced by 29.37% to $8.2 million in 2023, then climbed by 2.02% to $8.4 million in 2024, then climbed by 21.17% to $10.2 million in 2025, then plunged by 55.33% to $4.6 million in 2026.
  • Business Quant data shows PGEN's Accumulated Expenses at $4.6 million in Q1 2026, $10.2 million in Q4 2025, and $10.2 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.50 Mn
Mar 31, 2026 4.56 Mn
Dec 31, 2025 10.20 Mn
Sep 30, 2025 10.17 Mn
Jun 30, 2025 5.20 Mn
Mar 31, 2025 9.62 Mn
Dec 31, 2024 8.42 Mn
Sep 30, 2024 6.61 Mn
Jun 30, 2024 6.68 Mn
Mar 31, 2024 9.96 Mn
Dec 31, 2023 8.25 Mn
Sep 30, 2023 6.62 Mn
Jun 30, 2023 4.82 Mn
Mar 31, 2023 4.96 Mn
Dec 31, 2022 6.38 Mn
Sep 30, 2022 5.79 Mn
Jun 30, 2022 4.86 Mn
Mar 31, 2022 6.05 Mn
Dec 31, 2021 7.86 Mn
Sep 30, 2021 8.08 Mn